Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CC-5013 for Chronic lymphocytic leukaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 15 adverse event reports in the FDA FAERS database where CC-5013 was used for Chronic lymphocytic leukaemia.

Other Indications for CC-5013

Plasma cell myeloma (9) Mantle cell lymphoma (5)

Other Drugs Used for Chronic lymphocytic leukaemia

IBRUTINIB (37,003) VENETOCLAX (14,194) RITUXIMAB (7,231) OBINUTUZUMAB (4,557) ACALABRUTINIB (4,515) IDELALISIB (3,537) CYCLOPHOSPHAMIDE (3,085) FLUDARABINE (2,777) BENDAMUSTINE (2,561) CHLORAMBUCIL (1,242)

Related Pages

CC-5013 Full Profile All Chronic lymphocytic leukaemia Drugs CC-5013 Demographics CC-5013 Timeline